Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anabelle Brocard

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Investigative Dermatology|June 26, 2009
Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clonesAmir Khammari, Nathalie Labarrière, Virginie Vignard, et al.
Medical Mycology|March 13, 2012
Phaeohyphomycosis due to Alternaria infectoria: a single-center experience with utility of PCR for diagnosis and species identificationTiphaine Robert, Jean-Philippe Talarmin, Marion Leterrier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 3, 2017
Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature reviewClaire Rouzaud, Olivier Chosidow, Anabelle Brocard, et al.
Cancer Immunology, Immunotherapy : CII|June 6, 2007
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanomaAmir Khammari, Jean-Michel Nguyen, Marie Christine Pandolfino, et al.
Cancer Immunology, Immunotherapy : CII|April 8, 2015
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patientsAmir Khammari, Jean-Michel Nguyen, Melanie Saint-Jean, et al.
Journal of Immunology Research|May 12, 2018
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma PatientsMélanie Saint-Jean, Anne-Chantal Knol, Christelle Volteau, et al.
Experimental Dermatology|May 20, 2016
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baselineAnne C Knol, Audrey Vallée, Guillaume Herbreteau, et al.
Transplantation|January 19, 2017
Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 CasesEmilie Ducroux, Clemmie Martin, Jan Nico Bouwes Bavinck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year ResultsJacques Dantal, Emmanuel Morelon, Lionel Rostaing, et al.
The New England Journal of Medicine|July 27, 2012
Sirolimus and secondary skin-cancer prevention in kidney transplantationSylvie Euvrard, Emmanuel Morelon, Lionel Rostaing, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Investigative Dermatology|June 26, 2009
Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clonesAmir Khammari, Nathalie Labarrière, Virginie Vignard, et al.
Medical Mycology|March 13, 2012
Phaeohyphomycosis due to Alternaria infectoria: a single-center experience with utility of PCR for diagnosis and species identificationTiphaine Robert, Jean-Philippe Talarmin, Marion Leterrier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 3, 2017
Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature reviewClaire Rouzaud, Olivier Chosidow, Anabelle Brocard, et al.
Cancer Immunology, Immunotherapy : CII|June 6, 2007
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanomaAmir Khammari, Jean-Michel Nguyen, Marie Christine Pandolfino, et al.
Cancer Immunology, Immunotherapy : CII|April 8, 2015
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patientsAmir Khammari, Jean-Michel Nguyen, Melanie Saint-Jean, et al.
Journal of Immunology Research|May 12, 2018
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma PatientsMélanie Saint-Jean, Anne-Chantal Knol, Christelle Volteau, et al.
Experimental Dermatology|May 20, 2016
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baselineAnne C Knol, Audrey Vallée, Guillaume Herbreteau, et al.
Transplantation|January 19, 2017
Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 CasesEmilie Ducroux, Clemmie Martin, Jan Nico Bouwes Bavinck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year ResultsJacques Dantal, Emmanuel Morelon, Lionel Rostaing, et al.
The New England Journal of Medicine|July 27, 2012
Sirolimus and secondary skin-cancer prevention in kidney transplantationSylvie Euvrard, Emmanuel Morelon, Lionel Rostaing, et al.
Pageof 4